Publication | Closed Access
Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation
50
Citations
15
References
2004
Year
Cell TherapyTransplantationAllergyAutoimmune DiseaseStem Cell TransplantationImmunologyAutoimmunityRefractory Autoimmune CytopeniasImmunotherapyMedicineCell TransplantationGraft Rejection
| Year | Citations | |
|---|---|---|
Page 1
Page 1